nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—SHH—embryo—polycystic ovary syndrome	0.0316	0.087	CbGeAlD
Vismodegib—SHH—endometrium—polycystic ovary syndrome	0.0232	0.0636	CbGeAlD
Vismodegib—SMO—embryo—polycystic ovary syndrome	0.0221	0.0608	CbGeAlD
Vismodegib—Sorafenib—FLT4—polycystic ovary syndrome	0.0217	0.832	CrCbGaD
Vismodegib—CYP2C19—urine—polycystic ovary syndrome	0.0211	0.0581	CbGeAlD
Vismodegib—SMO—adrenal cortex—polycystic ovary syndrome	0.0181	0.0498	CbGeAlD
Vismodegib—CYP2C9—urine—polycystic ovary syndrome	0.0164	0.045	CbGeAlD
Vismodegib—SHH—endocrine gland—polycystic ovary syndrome	0.0162	0.0446	CbGeAlD
Vismodegib—SMO—endometrium—polycystic ovary syndrome	0.0162	0.0445	CbGeAlD
Vismodegib—SMO—uterus—polycystic ovary syndrome	0.0149	0.041	CbGeAlD
Vismodegib—SMO—pituitary gland—polycystic ovary syndrome	0.0147	0.0403	CbGeAlD
Vismodegib—SMO—adipose tissue—polycystic ovary syndrome	0.0146	0.0401	CbGeAlD
Vismodegib—SMO—adrenal gland—polycystic ovary syndrome	0.0131	0.036	CbGeAlD
Vismodegib—CYP3A4—urine—polycystic ovary syndrome	0.0125	0.0343	CbGeAlD
Vismodegib—SMO—female gonad—polycystic ovary syndrome	0.0122	0.0336	CbGeAlD
Vismodegib—SMO—vagina—polycystic ovary syndrome	0.0121	0.0333	CbGeAlD
Vismodegib—SMO—endocrine gland—polycystic ovary syndrome	0.0114	0.0312	CbGeAlD
Vismodegib—Azotaemia—Metformin—polycystic ovary syndrome	0.011	0.158	CcSEcCtD
Vismodegib—ORM1—endometrium—polycystic ovary syndrome	0.00708	0.0195	CbGeAlD
Vismodegib—ALB—adrenal gland—polycystic ovary syndrome	0.00502	0.0138	CbGeAlD
Vismodegib—ORM1—endocrine gland—polycystic ovary syndrome	0.00496	0.0136	CbGeAlD
Vismodegib—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00475	0.0131	CbGeAlD
Vismodegib—Sulfasalazine—PPARG—polycystic ovary syndrome	0.00438	0.168	CrCbGaD
Vismodegib—CYP2C8—endometrium—polycystic ovary syndrome	0.00436	0.012	CbGeAlD
Vismodegib—Pain in extremity—Metformin—polycystic ovary syndrome	0.00424	0.061	CcSEcCtD
Vismodegib—ABCG2—endometrium—polycystic ovary syndrome	0.00424	0.0117	CbGeAlD
Vismodegib—Dehydration—Metformin—polycystic ovary syndrome	0.00395	0.0567	CcSEcCtD
Vismodegib—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00395	0.0108	CbGeAlD
Vismodegib—ABCG2—uterus—polycystic ovary syndrome	0.00391	0.0107	CbGeAlD
Vismodegib—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00388	0.0557	CcSEcCtD
Vismodegib—ABCG2—pituitary gland—polycystic ovary syndrome	0.00384	0.0105	CbGeAlD
Vismodegib—Breast disorder—Metformin—polycystic ovary syndrome	0.00384	0.0551	CcSEcCtD
Vismodegib—ABCG2—adipose tissue—polycystic ovary syndrome	0.00382	0.0105	CbGeAlD
Vismodegib—CYP2C19—vagina—polycystic ovary syndrome	0.00374	0.0103	CbGeAlD
Vismodegib—CYP2C19—endocrine gland—polycystic ovary syndrome	0.0035	0.00963	CbGeAlD
Vismodegib—ABCG2—adrenal gland—polycystic ovary syndrome	0.00343	0.00942	CbGeAlD
Vismodegib—CYP2C8—vagina—polycystic ovary syndrome	0.00327	0.00898	CbGeAlD
Vismodegib—ABCG2—female gonad—polycystic ovary syndrome	0.0032	0.00879	CbGeAlD
Vismodegib—ABCG2—vagina—polycystic ovary syndrome	0.00318	0.00873	CbGeAlD
Vismodegib—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00306	0.0084	CbGeAlD
Vismodegib—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00289	0.0415	CcSEcCtD
Vismodegib—ABCB1—embryo—polycystic ovary syndrome	0.00286	0.00785	CbGeAlD
Vismodegib—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00272	0.00746	CbGeAlD
Vismodegib—Malnutrition—Metformin—polycystic ovary syndrome	0.00256	0.0367	CcSEcCtD
Vismodegib—Dysgeusia—Metformin—polycystic ovary syndrome	0.0025	0.036	CcSEcCtD
Vismodegib—Muscle spasms—Metformin—polycystic ovary syndrome	0.00246	0.0353	CcSEcCtD
Vismodegib—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00234	0.00644	CbGeAlD
Vismodegib—Myalgia—Metformin—polycystic ovary syndrome	0.00218	0.0313	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00216	0.0311	CcSEcCtD
Vismodegib—ABCB1—endometrium—polycystic ovary syndrome	0.00209	0.00575	CbGeAlD
Vismodegib—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00207	0.00569	CbGeAlD
Vismodegib—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00205	0.0294	CcSEcCtD
Vismodegib—Skin disorder—Metformin—polycystic ovary syndrome	0.00203	0.0291	CcSEcCtD
Vismodegib—ABCB1—uterus—polycystic ovary syndrome	0.00193	0.0053	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0019	0.0273	CcSEcCtD
Vismodegib—ABCB1—pituitary gland—polycystic ovary syndrome	0.00189	0.0052	CbGeAlD
Vismodegib—ABCB1—adipose tissue—polycystic ovary syndrome	0.00188	0.00518	CbGeAlD
Vismodegib—Dyspepsia—Metformin—polycystic ovary syndrome	0.00184	0.0264	CcSEcCtD
Vismodegib—Decreased appetite—Metformin—polycystic ovary syndrome	0.00181	0.0261	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0018	0.0259	CcSEcCtD
Vismodegib—Fatigue—Metformin—polycystic ovary syndrome	0.0018	0.0259	CcSEcCtD
Vismodegib—Constipation—Metformin—polycystic ovary syndrome	0.00178	0.0256	CcSEcCtD
Vismodegib—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00171	0.0245	CcSEcCtD
Vismodegib—ABCB1—adrenal gland—polycystic ovary syndrome	0.00169	0.00465	CbGeAlD
Vismodegib—Abdominal pain—Metformin—polycystic ovary syndrome	0.00165	0.0237	CcSEcCtD
Vismodegib—ABCB1—female gonad—polycystic ovary syndrome	0.00158	0.00433	CbGeAlD
Vismodegib—ABCB1—vagina—polycystic ovary syndrome	0.00157	0.00431	CbGeAlD
Vismodegib—Asthenia—Metformin—polycystic ovary syndrome	0.0015	0.0215	CcSEcCtD
Vismodegib—Pruritus—Metformin—polycystic ovary syndrome	0.00148	0.0212	CcSEcCtD
Vismodegib—ABCB1—endocrine gland—polycystic ovary syndrome	0.00147	0.00403	CbGeAlD
Vismodegib—Diarrhoea—Metformin—polycystic ovary syndrome	0.00143	0.0205	CcSEcCtD
Vismodegib—Vomiting—Metformin—polycystic ovary syndrome	0.00133	0.0191	CcSEcCtD
Vismodegib—Rash—Metformin—polycystic ovary syndrome	0.00132	0.0189	CcSEcCtD
Vismodegib—Dermatitis—Metformin—polycystic ovary syndrome	0.00131	0.0189	CcSEcCtD
Vismodegib—Nausea—Metformin—polycystic ovary syndrome	0.00124	0.0178	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000149	0.000275	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000145	0.000269	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000145	0.000268	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000145	0.000268	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000145	0.000267	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000144	0.000267	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000144	0.000266	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—LHB—polycystic ovary syndrome	0.000143	0.000265	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000143	0.000265	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000142	0.000263	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000141	0.000262	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	0.00014	0.000259	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000139	0.000257	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000139	0.000256	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000137	0.000254	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000137	0.000253	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000136	0.000251	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000135	0.00025	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000135	0.00025	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000134	0.000248	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000132	0.000244	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000132	0.000244	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000132	0.000244	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000132	0.000244	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000131	0.000242	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00013	0.00024	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000128	0.000236	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000128	0.000236	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000127	0.000234	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000126	0.000234	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000126	0.000233	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000126	0.000233	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000125	0.000232	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000125	0.000231	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000125	0.00023	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000123	0.000228	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000123	0.000228	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	0.000121	0.000223	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.00012	0.000222	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00012	0.000221	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000119	0.000221	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000119	0.000221	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000118	0.000219	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000117	0.000217	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000116	0.000215	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	0.000116	0.000215	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000115	0.000212	CbGpPWpGaD
Vismodegib—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000114	0.000211	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000114	0.000211	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000113	0.000209	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000113	0.000209	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000113	0.000208	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000112	0.000208	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	0.000112	0.000207	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	0.00011	0.000204	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.00011	0.000204	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00011	0.000204	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000109	0.000202	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000108	0.000199	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000107	0.000198	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—polycystic ovary syndrome	0.000106	0.000197	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000105	0.000194	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000104	0.000193	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000103	0.000191	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000103	0.00019	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000103	0.00019	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000103	0.00019	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000102	0.000189	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000102	0.000189	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000102	0.000189	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000102	0.000188	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000101	0.000187	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—STAR—polycystic ovary syndrome	9.98e-05	0.000185	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.98e-05	0.000185	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.77e-05	0.000181	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	9.74e-05	0.00018	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	9.69e-05	0.000179	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.63e-05	0.000178	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.58e-05	0.000177	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.56e-05	0.000177	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.54e-05	0.000177	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	9.51e-05	0.000176	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.33e-05	0.000172	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.22e-05	0.00017	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.13e-05	0.000169	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	9.12e-05	0.000169	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.08e-05	0.000168	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	9.06e-05	0.000168	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	8.92e-05	0.000165	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	8.9e-05	0.000165	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TH—polycystic ovary syndrome	8.89e-05	0.000164	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	8.88e-05	0.000164	CbGpPWpGaD
Vismodegib—ALB—Metabolism—LHB—polycystic ovary syndrome	8.83e-05	0.000163	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	8.7e-05	0.000161	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	8.68e-05	0.000161	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	8.64e-05	0.00016	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	8.63e-05	0.00016	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.6e-05	0.000159	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	8.49e-05	0.000157	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	8.41e-05	0.000156	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.37e-05	0.000155	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	8.36e-05	0.000155	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.31e-05	0.000154	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.15e-05	0.000151	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	8.13e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.11e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.11e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	7.93e-05	0.000147	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.93e-05	0.000147	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.84e-05	0.000145	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	7.75e-05	0.000143	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—LHB—polycystic ovary syndrome	7.74e-05	0.000143	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	7.74e-05	0.000143	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	7.7e-05	0.000142	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	7.56e-05	0.00014	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	7.51e-05	0.000139	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	7.5e-05	0.000139	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—polycystic ovary syndrome	7.46e-05	0.000138	CbGpPWpGaD
Vismodegib—ALB—Metabolism—RRM2—polycystic ovary syndrome	7.45e-05	0.000138	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.43e-05	0.000137	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	7.33e-05	0.000136	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	7.25e-05	0.000134	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.23e-05	0.000134	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.23e-05	0.000134	CbGpPWpGaD
Vismodegib—ALB—Metabolism—YAP1—polycystic ovary syndrome	7.18e-05	0.000133	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF1—polycystic ovary syndrome	7.15e-05	0.000132	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT2—polycystic ovary syndrome	7.15e-05	0.000132	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—polycystic ovary syndrome	7.07e-05	0.000131	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.07e-05	0.000131	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	6.94e-05	0.000128	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	6.91e-05	0.000128	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	6.91e-05	0.000128	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NAMPT—polycystic ovary syndrome	6.9e-05	0.000128	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.9e-05	0.000128	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.86e-05	0.000127	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	6.86e-05	0.000127	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.84e-05	0.000127	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	6.82e-05	0.000126	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.81e-05	0.000126	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.8e-05	0.000126	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	6.79e-05	0.000126	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.77e-05	0.000125	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	6.74e-05	0.000125	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	6.69e-05	0.000124	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	6.55e-05	0.000121	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	6.53e-05	0.000121	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	6.47e-05	0.00012	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	6.45e-05	0.000119	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.45e-05	0.000119	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.44e-05	0.000119	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	6.37e-05	0.000118	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	6.34e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.3e-05	0.000117	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	6.29e-05	0.000116	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.2e-05	0.000115	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.16e-05	0.000114	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.15e-05	0.000114	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.12e-05	0.000113	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	6.11e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.1e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.08e-05	0.000112	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	6.05e-05	0.000112	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	5.97e-05	0.00011	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.88e-05	0.000109	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	5.78e-05	0.000107	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	5.69e-05	0.000105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.65e-05	0.000105	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	5.64e-05	0.000104	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.62e-05	0.000104	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.58e-05	0.000103	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	5.55e-05	0.000103	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.54e-05	0.000102	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TH—polycystic ovary syndrome	5.51e-05	0.000102	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TH—polycystic ovary syndrome	5.48e-05	0.000101	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.48e-05	0.000101	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.36e-05	9.92e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5.33e-05	9.87e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.27e-05	9.75e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.23e-05	9.67e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.19e-05	9.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.04e-05	9.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	5.02e-05	9.28e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	4.95e-05	9.16e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.92e-05	9.1e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—polycystic ovary syndrome	4.88e-05	9.03e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—INS—polycystic ovary syndrome	4.86e-05	8.98e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TH—polycystic ovary syndrome	4.8e-05	8.89e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	4.79e-05	8.86e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.77e-05	8.82e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	4.67e-05	8.64e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.67e-05	8.64e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.66e-05	8.62e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.51e-05	8.35e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.5e-05	8.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.5e-05	8.33e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.49e-05	8.3e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.48e-05	8.28e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	4.39e-05	8.13e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.37e-05	8.08e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.29e-05	7.93e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.26e-05	7.89e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.15e-05	7.68e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.1e-05	7.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.07e-05	7.52e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	4.04e-05	7.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.02e-05	7.44e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.02e-05	7.43e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.92e-05	7.25e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.88e-05	7.17e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.83e-05	7.08e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	3.79e-05	7.01e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.77e-05	6.97e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.74e-05	6.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.73e-05	6.89e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.68e-05	6.81e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.66e-05	6.78e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.63e-05	6.71e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.54e-05	6.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.49e-05	6.46e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.48e-05	6.43e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.42e-05	6.33e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.38e-05	6.26e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.31e-05	6.12e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.3e-05	6.11e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.08e-05	5.71e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.07e-05	5.69e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—polycystic ovary syndrome	3.06e-05	5.65e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.03e-05	5.61e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.01e-05	5.58e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—polycystic ovary syndrome	3.01e-05	5.58e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—INS—polycystic ovary syndrome	3e-05	5.54e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.96e-05	5.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.88e-05	5.33e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.74e-05	5.07e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.71e-05	5.01e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.71e-05	5e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.69e-05	4.98e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.68e-05	4.95e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.64e-05	4.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.63e-05	4.86e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.5e-05	4.63e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.47e-05	4.56e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.45e-05	4.54e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.42e-05	4.47e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.3e-05	4.26e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.18e-05	4.04e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.03e-05	3.76e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.65e-05	3.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.63e-05	3.01e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.62e-05	2.99e-05	CbGpPWpGaD
